Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Velafermin

Next Previous
X
Search
Drug Profile

Velafermin

Alternative Names: CG-53135; CG53135-05; FGF 20; Fibroblast growth factor-20; rhFGF-20

Latest Information Update: 17 Mar 2016

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CuraGen Corporation
  • Class Anti-inflammatories; Expectorants; Fibroblast growth factors
  • Mechanism of Action Intercellular signalling peptide and protein stimulants; Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Stomatitis
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Inflammatory bowel diseases; Stomatitis

Most Recent Events

  • 10 Aug 2007 CuraGen completes enrolment in the CLN-12 trial for oral mucositis in the US
  • 01 Jun 2006 CuraGen has initiated enrolment in the CLN-12 trial for oral mucositis in the US, evaluating a single dose of velafermin
  • 24 Feb 2006 Data from a media release have been added to the adverse events and Mouth disorders therapeutic trials sections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top